期刊文献+

甲胎蛋白水平升高与乙型肝炎阳性统计分析

下载PDF
导出
摘要 目的探讨甲胎蛋白检测水平高低,乙型肝炎感染阳性情况。方法统计2015年1月1日到2019年3月31日检查甲胎蛋白的患者,其中统计分析甲胎蛋白结果大于参考值6.05 IU/mL以上的患者,同时统计检查乙型肝炎两对半和丙型肝炎抗体的结果。结果统计4991例甲胎蛋白检测人次,其中甲胎蛋白值大于参考值6.05 IU/mL以上233例,男性181例,占77.7%,乙肝阳性占78.7%,女性52例,占22.3%,乙肝阳性占21.3%,平均年龄,男50.9岁,女52.8岁,男女甲胎蛋白升高及乙肝感染存在明显统计学差异(P<0.01)。以甲胎蛋白结果大于20 IU/mL以上,与6.05~20 IU/mL分组比较,分别为乙肝阳性91.1%、阴性8.9%和乙肝阳性46.7%、阴性53.3%,甲胎蛋白值高低与乙肝阳性存在明显统计学差异(P<0.01)。结论甲胎蛋白升高主要集中在中老人男性患者,随着患者甲胎蛋白水平增加,乙肝阳性率越普遍,甲胎蛋白高低与乙肝阳性一致性高度重合,乙型肝炎感染是引起男性原发性肝癌的主要原因。
出处 《现代医药卫生》 2019年第S01期20-22,共3页 Journal of Modern Medicine & Health
  • 相关文献

参考文献4

二级参考文献47

  • 1Lai CL,Shouval D,Lok AS,陈楠(摘译),张占卿(审校).恩替卡韦与拉米夫定治疗HBeAg阴性慢性乙型肝炎的对照研究[J].世界感染杂志,2006,6(4):396-396. 被引量:201
  • 2Bruix J, Sherman M, Llovet JM, et ol. Clinical management of he- patocellular carcinoma. Conclusions of the Bareelona-2000 EASL conference. European Association for the Study of the Liver[J]. J Hepatol, 2001, 35(3):421-430.
  • 3National Cancer Institute. Levels of evidence for adult and pedi- atric cancer treatment studies (PDQ?)[EB/0L]. [2012-07-12]. http:// www.cancer.gov/cancertopics/pdq/levels-evidence-aduh-treatment/ HealthProfessional/page 1.
  • 4European Association for the study of the liver; European Organi- sation for research and treatment of cancer. EASL-EORTC clini- cal practice guidelines: management of hepatoeellular carcinoma [J]. J Hepatol, 2012, 56(4):908-943.
  • 5Singal AG, Volk ML, Jensen D, eta/. A sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus[J ]. Clin Gastroenteml Hepatol, 2010, 8(3):280-288.
  • 6Lok AS, Seeff LB, Morgan TR, eta]. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related ad- vanced liver disease[J]. Gastroenterology, 2009, 136(1):138-148.
  • 7Marrero JA, Su GL, Wei W, et ol. Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chro- nic liver disease in American patients[J]. Hepatology, 2003, 37(5): 1114-1121.
  • 8Bruix J, Sherman M. Management of hepatocellular carcinoma[J]. Hepatology, 2005, 42(5):1208-1236.
  • 9Bruix J, Sherman M. Management of hepatocellular carcinoma: an update[J]. Hepatology, 2011, 53(3):1020-1022.
  • 10International Consensus Group for Hepatocellular Neoplasia. Pa- thologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia[J]. He patology, 2009, 49(2):658-664.

共引文献538

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部